In Silico analysis of CYP2C19 genetic variants and their Impact on Pharmacogenomics
This study provides an in silico analysis of four CYP2C19 genetic variants—rs3758581, rs113994117, rs12248560, and rs28399504—to predict their functional impact on drug metabolism. Using SIFT and PolyPhen-2, the research categorizes these mutations into metabolic phenotypes to improve personalized medicine and safety for drugs like Clopidogrel.
Authors
- Aakriti Kaushal
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-03-22
- DOI
- https://doi.org/10.5281/zenodo.19162517
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00